Literature DB >> 33865475

The role and challenges of cluster randomised trials for global health.

Louis Dron1, Monica Taljaard2, Yin Bun Cheung3, Rebecca Grais4, Nathan Ford5, Kristian Thorlund1, Fyezah Jahan6, Etheldreda Nakimuli-Mpungu7, Denis Xavier8, Zulfiqar A Bhutta9, Jay J H Park10, Edward J Mills11.   

Abstract

Evaluating whether an intervention works when trialled in groups of individuals can pose complex challenges for clinical research. Cluster randomised controlled trials involve the random allocation of groups or clusters of individuals to receive an intervention, and they are commonly used in global health research. In this paper, we describe the potential reasons for the increasing popularity of cluster trials in low-income and middle-income countries. We also draw on key areas of global health research for an assessment of common trial planning practices, and we address their methodological shortcomings and pitfalls. Lastly, we discuss alternative approaches for population-level intervention trials that could be useful for research undertaken in low-income and middle-income countries for situations in which the use of cluster randomisation might not be appropriate.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Year:  2021        PMID: 33865475     DOI: 10.1016/S2214-109X(20)30541-6

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  7 in total

1.  Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure.

Authors:  Qinyuan Li; Qi Zhou; Kehu Yang; Zhengxiu Luo; Yaolong Chen
Journal:  Lancet Respir Med       Date:  2022-06       Impact factor: 102.642

2.  Ratio estimators of intervention effects on event rates in cluster randomized trials.

Authors:  Xiangmei Ma; Paul Milligan; Kwok Fai Lam; Yin Bun Cheung
Journal:  Stat Med       Date:  2021-10-15       Impact factor: 2.497

Review 3.  How COVID-19 has fundamentally changed clinical research in global health.

Authors:  Jay J H Park; Robin Mogg; Gerald E Smith; Etheldreda Nakimuli-Mpungu; Fyezah Jehan; Craig R Rayner; Jeanine Condo; Eric H Decloedt; Jean B Nachega; Gilmar Reis; Edward J Mills
Journal:  Lancet Glob Health       Date:  2021-05       Impact factor: 38.927

4.  Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial.

Authors:  Lindsey Wu; Michelle S Hsiang; Lisa M Prach; Leah Schrubbe; Henry Ntuku; Mi-Suk Kang Dufour; Brooke Whittemore; Valerie Scott; Joy Yala; Kathryn W Roberts; Catriona Patterson; Joseph Biggs; Tom Hall; Kevin K A Tetteh; Cara Smith Gueye; Bryan Greenhouse; Adam Bennett; Jennifer L Smith; Stark Katokele; Petrina Uusiku; Davis Mumbengegwi; Roly Gosling; Chris Drakeley; Immo Kleinschmidt
Journal:  EClinicalMedicine       Date:  2022-02-14

5.  Tuberculosis Treatment Compliance Under Smartphone-Based Video-Observed Therapy Versus Community-Based Directly Observed Therapy: Protocol for a Cluster Randomized Controlled Trial.

Authors:  Ponlagrit Kumwichar; Virasakdi Chongsuvivatwong; Tagoon Prappre
Journal:  JMIR Res Protoc       Date:  2022-07-08

6.  Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.

Authors:  Sibonakaliso Vilakati; Nontokozo Mngadi; Jade Benjamin-Chung; Nomcebo Dlamini; Mi-Suk Kang Dufour; Brooke Whittemore; Khayelihle Bhangu; Lisa M Prach; Kimberly Baltzell; Nomcebo Nhlabathi; Calisile Malambe; Bongani Dlamini; Danica Helb; Bryan Greenhouse; Gugu Maphalala; Deepa Pindolia; Muhindo Kalungero; Getahun Tesfa; Roly Gosling; Nyasatu Ntshalintshali; Simon Kunene; Michelle S Hsiang
Journal:  BMJ Glob Health       Date:  2021-06

Review 7.  Urgently seeking efficiency and sustainability of clinical trials in global health.

Authors:  Jay J H Park; Rebecca F Grais; Monica Taljaard; Etheldreda Nakimuli-Mpungu; Fyezah Jehan; Jean B Nachega; Nathan Ford; Denis Xavier; Andre P Kengne; Per Ashorn; Maria Eugenia Socias; Zulfiqar A Bhutta; Edward J Mills
Journal:  Lancet Glob Health       Date:  2021-05       Impact factor: 26.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.